Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
BASF SE, an initialism and portmanteau of its original name Badische Anilin- und Sodafabrik, is a European multinational company and the largest chemical producer in the world. Its headquarters are located in Ludwigshafen, Germany.
Raisio Oyj, known internationally as Raisio Group, is a Finnish company specialised in healthy, responsibly produced food and ingredients.
Sandoz Group AG is a Swiss-Germany based company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form the company Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland. Sandoz is one of the leading global generics business.
Araldite is a registered trademark of Huntsman Advanced Materials referring to their range of engineering and structural epoxy, acrylic, and polyurethane adhesives. Swiss manufacturers originally launched Araldite DIY adhesive products in 1946. The first batches of Araldite epoxy resins, for which the brand is best known, were made in Duxford, England in 1950.
Chiron Corporation was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.
Huntsman Corporation is an American multinational manufacturer and marketer of chemical products for consumers and industrial customers. Huntsman manufactures assorted polyurethanes, performance products, and adhesives for customers like BMW, GE, Chevron, Procter & Gamble, Unilever and Walkaroo. With global headquarters in The Woodlands, Texas, it operates more than 70 manufacturing, R&D and operations facilities in over 30 countries and employ approximately 9,000 associates across four business divisions. Huntsman Corporation had 2020 revenues of approximately $6 billion.
Syngenta AG is a provider of agricultural science and technology, in particular seeds and pesticides with its management headquarters in Basel, Switzerland. It is owned by ChemChina, a Chinese state-owned enterprise.
Alcon is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It is headquartered in Geneva, Switzerland and has a major presence in Fort Worth, Texas, United States, where it employs about 4,500 people.
Clariant AG is a Swiss multinational speciality chemical company, formed in 1995 as a spin-off from Sandoz. Headquartered in Muttenz, Switzerland, the public company encompasses 74 subsidiaries in 36 countries (2022). Major manufacturing sites are located in Europe, North America, South America, China, and India. In 2022, sales from continuing operations were 5.198 billion CHF.
Daniel Lucius Vasella is a Swiss medical doctor, author, and executive who served as CEO and chairman of the Swiss pharmaceutical company Novartis AG, the world's fifth largest drug company. During his tenure Novartis shares fell 10%, compared to the industry average. In February 2013 Vasella was awarded close to $78 million in a "golden handshake"
Ciba or CIBA may refer to:
The Novartis Foundation is a non-profit organization and part of the corporate responsibility portfolio of Novartis in Basel, Switzerland. The foundation conducts projects to improve health, mostly in sub-Saharan Africa and in south-east Asia.
Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index.
The Clayton Aniline Company Ltd. was a British manufacturer of dyestuffs, founded in 1876 by Charles Dreyfus in Clayton, Manchester.
Specialty chemicals are particular chemical products which provide a wide variety of effects on which many other industry sectors rely. Some of the categories of speciality chemicals are adhesives, agrichemicals, cleaning materials, colors, cosmetic additives, construction chemicals, elastomers, flavors, food additives, fragrances, industrial gases, lubricants, paints, polymers, surfactants, and textile auxiliaries. Other industrial sectors such as automotive, aerospace, food, cosmetics, agriculture, manufacturing, and textiles are highly dependent on such products.
Joseph Tatnall House, also known as the "Oliver Evans House," is a historic home located at Newport, New Castle County, Delaware. The house is alternatively named after Newport's favorite son Oliver Evans (1755-1819), although he had no apparent historical association with it.
The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. It contributes to 5.7% of the gross domestic product of Switzerland and contributes to 30% of the country's exports. In 2017 about 30% of Swiss exports were chemical products. In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion.
Jörg Reinhardt has been Chairman of the Board of Directors of the Swiss pharmaceutical group Novartis AG since 2013. Since 2017, he has also been a member of the Board of Directors of the Swiss reinsurance group Swiss Re.
